Cpwm, LLC Eli Lilly & CO Transaction History

Cpwm, LLC

$1.06 Billion
Q3 2022

A detailed history of Cpwm, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cpwm, LLC holds 8,020 shares of LLY stock, worth $6.88 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

8,020

Previous 8,506 5.71%

Holding current value

$6.88 Million

Previous $2.76 Million 5.98%

% of portfolio

0.24%

Previous 0.25%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $144,089 - $164,204	-486 Reduced 5.71%	8,020 $2.59 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $297,683 - $349,524	-1,068 Reduced 11.16%	8,506 $2.76 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $15,958 - $19,832	68 Added 0.72%	9,574 $2.74 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $664 - $818	-3 Reduced 0.03%	9,506 $2.2 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $361 - $467	2 Added 0.02%	9,509 $2.18 Million

Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $821 - $1,063	5 Added 0.05%	9,507 $1.78 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $24,004 - $31,763	184 Added 1.97%	9,502 $1.6 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $89,925 - $104,014	-615 Reduced 6.19%	9,318 $1.38 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $79,669 - $95,881	584 Added 6.25%	9,933 $1.63 Million
Q1 2020 May 11, 2020	BUY	$119.05 - $147.35 $7,738 - $9,577	65 Added 0.7%	9,349 $1.3 Million
Q4 2019 Feb 12, 2020	BUY	$106.92 - $132.43 $80,938 - $100,249	757 Added 8.88%	9,284 $1.22 Million
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $5,659 - $6,156	53 Added 0.63%	8,527 $954,000
Q2 2019 Aug 02, 2019	SELL	$110.79 - $129.32 $5,539 - $6,466	-50 Reduced 0.59%	8,474 $939,000
Q1 2019 May 06, 2019	SELL	$111.31 - $131.02 $7,346 - $8,647	-66 Reduced 0.77%	8,524 $1.11 Million
Q4 2018 Feb 08, 2019	SELL	$105.9 - $118.64 $7,730 - $8,660	-73 Reduced 0.84%	8,590 $994,000
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $9,959 - $12,447	116 Added 1.36%	8,663 $930,000
Q2 2018 Dec 21, 2018	BUY	$75.7 - $86.88 $280,544 - $321,977	3,706 Added 76.55%	8,547 $729,000
Q2 2018 Aug 09, 2018	SELL	$75.7 - $86.88 $280,165 - $321,542	-3,701 Reduced 43.33%	4,841 $413,000
Q1 2018 Dec 21, 2018	BUY	$74.21 - $87.6 $385,446 - $454,994	5,194 Added 155.14%	8,542 $661,000
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $111,314 - $131,400	-1,500 Reduced 30.94%	3,348 $259,000
Q4 2017 Feb 02, 2018	BUY	$81.94 - $87.89 $21,058 - $22,587	257 Added 5.6%	4,848 $409,000
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $123,774 - $137,377	-1,606 Reduced 25.92%	4,591 $393,000
Q2 2017 Aug 14, 2017	BUY	N/A	6,197	6,197 $510,000

Others Institutions Holding LLY

# of Institutions

3,747

Shares Held

737M

Call Options Held

7.09M

Put Options Held

7.22M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $815B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cpwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cpwm, LLC with notifications on news.

Account